Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-25
1997-12-16
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514471, 514472, 514473, 549222, 549331, 549476, 549479, 549480, C07D30732, A61K 3134
Patent
active
056985843
ABSTRACT:
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
REFERENCES:
patent: 5344991 (1994-09-01), Reitz et al.
patent: 5393790 (1995-02-01), Reitz et al.
Taniguchi, et al., Chem. Pharm. Bull. 42(4) pp. 896-902 (1994).
Li., et al., J. of Med. Chem., vol. 38, No. 22, pp. 4570-4578 (1995).
Black Cameron
Hamel Pierre
Han Yongxin
Hughes Gregory
Leger Serge
Dentz Bernard
Merck Frosst Canada Inc.
Panzer Curtis C.
Rose David L.
LandOfFree
3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to COX-2 inhi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to COX-2 inhi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to COX-2 inhi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-206751